Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails. “Every developer out there advancing CAR T ...
Positive Development Raises $51.5M to Expand Nation’s Leading Developmental Therapy Model for Autism
Funding fuels expansion of the country’s most established developmental therapy model. Series C round led by aMoon Fund, B Capital and Flare Capital Partners with participation from Healthworx, ...
DUBLIN--(BUSINESS WIRE)--The "Innovation Waves in Immuno-oncology Therapy Development" report has been added to ResearchAndMarkets.com's offering. This study discusses the key trends and technologies ...
Since the FDA first approved CAR-T cell therapy in 2017, eight CAR-T drugs have emerged, six of which have been fully approved by the FDA. This groundbreaking cell therapy has brought about a series ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback